期刊名:Antibodies
期刊主页:https://www.mdpi.com/journal/antibodies
本期编辑荐读为您精选2025年发表于 Antibodies 期刊的十篇高浏览文章。希望能为相关领域学者提供新的思路和参考,欢迎阅读。
1.
Immune Cell Engagers: Advancing Precision Immunotherapy for Cancer Treatment
免疫细胞激活剂:推动癌症精准免疫疗法的发展
文章链接: https://www.mdpi.com/2073-4468/14/1/16
In, H.; Park, M.; Lee, H.; Han, K.H. Immune Cell Engagers: Advancing Precision Immunotherapy for Cancer Treatment. Antibodies 2025, 14, 16.
2.
Fragment-Based Immune Cell Engager Antibodies in Treatment of Cancer, Infectious and Autoimmune Diseases: Lessons and Insights from Clinical and Translational Studies
基于片段的免疫细胞衔接抗体在癌症、传染病和自身免疫性疾病治疗中的应用:来自临床和转化研究的经验和见解
文章链接: https://www.mdpi.com/2073-4468/14/3/52
Yang, G.; Massumi, M. Fragment-Based Immune Cell Engager Antibodies in Treatment of Cancer, Infectious and Autoimmune Diseases: Lessons and Insights from Clinical and Translational Studies. Antibodies 2025, 14, 52.
3.
Challenges and Insights in Absolute Quantification of Recombinant Therapeutic Antibodies by Mass Spectrometry: An Introductory Review
利用质谱法对重组治疗性抗体进行绝对定量分析的挑战与见解:一篇入门性综述
文章链接: https://www.mdpi.com/2073-4468/14/1/3
Döring, S.; Weller, M.G.; Reinders, Y.; Konthur, Z.; Jaeger, C. Challenges and Insights in Absolute Quantification of Recombinant Therapeutic Antibodies by Mass Spectrometry: An Introductory Review. Antibodies 2025, 14, 3.
4.
Anti-ADAMTS13 Autoantibodies in Immune-Mediated Thrombotic Thrombocytopenic Purpura
免疫介导的血栓性血小板减少性紫癜中的抗ADAMTS13自身抗体
文章链接: https://www.mdpi.com/2073-4468/14/1/24
Snyder, M.R.; Maitta, R.W. Anti-ADAMTS13 Autoantibodies in Immune-Mediated Thrombotic Thrombocytopenic Purpura. Antibodies 2025, 14, 24.
5.
How Broadly Neutralising Antibodies Are Redefining Immunity to Influenza
广谱中和抗体如何重新定义流感免疫力
文章链接: https://www.mdpi.com/2073-4468/14/1/4
Steventon, R.; Stolle, L.; Thompson, C.P. How Broadly Neutralising Antibodies Are Redefining Immunity to Influenza. Antibodies 2025, 14, 4.
6.
IgG to Galactose-Alpha-1,3-Galactose: Impact of Alpha-Gal IgE Sensitization, Blood Type, and Tick Bites
IgG 抗半乳糖-α-1,3-半乳糖:α-半乳糖 IgE 致敏、血型和蜱虫叮咬的影响
文章链接: https://www.mdpi.com/2073-4468/14/2/43
Ailsworth, S.M.; MacCallum, M.; Richards, N.E.; Workman, L.J.; Schoppee Bortz, P.; Makin, T.; Platts-Mills, T.A.E.; Wilson, J.M. IgG to Galactose-Alpha-1,3-Galactose: Impact of Alpha-Gal IgE Sensitization, Blood Type, and Tick Bites. Antibodies 2025, 14, 43.
7.
Avian Antibodies as Potential Therapeutic Tools
禽类抗体作为潜在的治疗工具
文章链接: https://www.mdpi.com/2073-4468/14/1/18
Eriksson, M.; Larsson, A. Avian Antibodies as Potential Therapeutic Tools. Antibodies 2025, 14, 18.
8.
Development of Fully Human Antibodies Targeting SIRPα and PLA2G7 for Cancer Therapy
开发靶向SIRPα和PLA2G7的全人源抗体用于癌症治疗
文章链接: https://www.mdpi.com/2073-4468/14/1/21
Shin, S.; Baek, D.-S.; Mellors, J.W.; Dimitrov, D.S.; Li, W. Development of Fully Human Antibodies Targeting SIRPα and PLA2G7 for Cancer Therapy. Antibodies 2025, 14, 21.
9.
Future Landscape of Anti-Claudin 18.2 Antibodies in Gastric Adenocarcinoma
抗Claudin 18.2抗体在胃腺癌中的未来前景
文章链接: https://www.mdpi.com/2073-4468/14/1/26
Covert, W.M.; Rogers, J.E. Future Landscape of Anti-Claudin 18.2 Antibodies in Gastric Adenocarcinoma. Antibodies 2025, 14, 26.
10.
In Vitro Functional Validation of an Anti-FREM2 Nanobody for Glioblastoma Cell Targeting
抗FREM2纳米抗体靶向胶质母细胞瘤细胞的体外功能验证
文章链接: https://www.mdpi.com/2073-4468/14/1/8
Krapez, G.; Šamec, N.; Zottel, A.; Katrašnik, M.; Kump, A.; Šribar, J.; Kri?aj, I.; Stojan, J.; Romih, R.; Bajc, G.; et al. In Vitro Functional Validation of an Anti-FREM2 Nanobody for Glioblastoma Cell Targeting. Antibodies 2025, 14, 8.
Antibodies期刊介绍
主编:Arne Skerra, Technical University of Munich, Germany
期刊主题涵盖抗体和体液免疫反应、抗体的发现、产生和选择、抗体结构和功能、抗体工程、结合物和融合蛋白、生物医学研究和治疗中的抗体。
|
2024 Impact Factor
|
2.7
|
|
2024 CiteScore
|
4.5
|
|
Time to First Decision
|
22.2 Days
|
|
Acceptance to Publication
|
4.6 Days
|
特别声明:本文转载仅仅是出于传播信息的需要,并不意味着代表本网站观点或证实其内容的真实性;如其他媒体、网站或个人从本网站转载使用,须保留本网站注明的“来源”,并自负版权等法律责任;作者如果不希望被转载或者联系转载稿费等事宜,请与我们接洽。